Bellerophon Therapeutics, Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2019 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Bellerophon Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2019 to Q3 2023.
  • Bellerophon Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2023 was $109K, a 132% increase year-over-year.
  • Bellerophon Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $135K, a 2600% increase from 2021.
  • Bellerophon Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was $5K.
  • Bellerophon Therapeutics, Inc. annual Nonoperating Income (Expense) for 2020 was -$250K, a 163% decline from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $109K +$62K +132% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $121K +$102K +537% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q4 2022 $135K $68K +$67K +6700% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-31
Q3 2022 $68K $47K +$45K +2250% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $23K $19K +$18K +1800% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $5K $1K $0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-11
Q4 2021 $5K $1K +$301K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$296K $2K -$7K -77.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$289K $1K -$6K -85.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$283K $1K -$33K -97.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 -$250K -$300K -$357K -626% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-11
Q3 2020 $107K $9K -$80K -89.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $187K $7K -$114K -94.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $301K $34K -$96K -73.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 $397K $57K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 $89K Jul 1, 2019 Sep 30, 2019 10-K 2021-03-11
Q2 2019 $121K Apr 1, 2019 Jun 30, 2019 10-K 2021-03-11
Q1 2019 $130K Jan 1, 2019 Mar 31, 2019 10-K 2021-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.